No article content yet.
Timeline
No Timeline data yet.
Invested in
Patents
Further Resources
No Further Resources data yet.
Brian L. Kotzin, M.D., joined Nektar Therapeutics in April 2017 as Head of Clinical Development for the company’s immunology program and was appointed Senior Vice President and Chief Medical Officer in April 2022.